We highly recommend enabling Javascript while using the BlackBoxRX site.

Lidocaine, viscous (Oral solution)

WARNING: Life-threatening and fatal events in infants and young children

  • Postmarketing cases of seizures, cardiopulmonary arrest, and death in patients under the age of 3 years have been reported with use of Xylocaine 2% Viscous Solution when it was not administered in strict adherence to the dosing and administration recommendations. In the setting of teething pain, Xylocaine 2% Viscous Solution should generally not be used. For other conditions, the use of the product in patients less than 3 years of age should be limited to those situations where safer alternatives are not available or have been tried but failed.
  • To decrease the risk of serious adverse events with use of Xylocaine 2% Viscous Solution, instruct caregivers to strictly adhere to the prescribed dose and frequency of administration and store the prescription bottle safely out of reach of children

FDA and Industry Communications

Index to FDA Drug Safety Information

Package Inserts

Lidocaine, Viscous

Updated January 2018